Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial

Volker Kunzmann, Jens T. Siveke, Hana Algül, Eray Goekkurt, Gabriele Margareta Siegler, Uwe M. Martens, Dirk Waldschmidt, Uwe Pelzer, Martin Fuchs, Frank Kullmann, Stefan Boeck, Thomas J. Ettrich, Swantje Held, Ralph Keller, Ingo Klein, Christoph‐Thomas Germer, H. J. Stein, Helmut Friess, Marcus Bahra, Ralf Jakobs, Ingo Hartlapp, Volker Heinemann, Elke Hennes, Udo Lindig, Thomas Geer, Michael Ståhl, M. Senkal, Thomas Südhoff, Matthias Egger, Christoph Kahl, Christina Große-Thie, Marcel Reiser, Stefan Mahlmann, Peter Fix, H. Schulz, Georg Maschmeyer, Wolfgang Blau